Cargando…
Tramadol’s Potential as a Gateway to Opioid Use Disorder
Autores principales: | Choi, Michael, Bins, Griffin, Konakanchi, Jaya Sri, Sethi, Roopa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Kansas Medical Center
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833982/ https://www.ncbi.nlm.nih.gov/pubmed/33643523 http://dx.doi.org/10.17161/kjm.vol1413513 |
Ejemplares similares
-
Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022) -
Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
por: Weesner, Elizabeth, et al.
Publicado: (2022) -
A Case Series of Spouses Undergoing Rapid Micro-Induction Technique of Buprenorphine Initiation from Methadone
por: Rampetsreiter, Kyle R., et al.
Publicado: (2023) -
Kratom use disorder as a gateway to an opioid use disorder
por: Borges, A. C., et al.
Publicado: (2023) -
Use of Tramadol for Management of Opioid Use Disorders: Rationale and Recommendations
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2018)